BlackRock
NVOS

BlackRock’s Novo Integrated Sciences, Inc. Common Stock NVOS Stock Holding History

BlackRock’s Portfolio NVOS Stock Details NVOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-290,451
Closed -$81.6K – 5529
2024
Q3 		$81.6K Hold
290,451
– – ﹤0.01% 4714
2024
Q2 		$218K Sell
290,451
-1,470
-0.5% -$941 ﹤0.01% 4534
2024
Q1 		$142K Hold
291,921
– – ﹤0.01% 4659
2023
Q4 		$240K Buy
291,921
+1
+0% +$2 ﹤0.01% 4592
2023
Q3 		$871K Buy
+291,920
New +$533K ﹤0.01% 4282
2023
Q2 		– Sell
-229
Closed -$281 – 5644
2023
Q1 		$281 Sell
229
-2,559
-92% -$3.4K ﹤0.01% 5506
2022
Q4 		$5.61K Buy
2,788
+61
+2% +$210 ﹤0.01% 5514
2022
Q3 		$28K Sell
2,727
-77
-3% -$1.25K ﹤0.01% 5463
2022
Q2 		$52K Buy
2,804
+436
+18% +$8.9K ﹤0.01% 5403
2022
Q1 		$54K Buy
2,368
+1,264
+114% +$21K ﹤0.01% 5410
2021
Q4 		$16K Sell
1,104
-817
-43% -$12.9K ﹤0.01% 5570
2021
Q3 		$35K Sell
1,921
-42
-2% -$828 ﹤0.01% 5338
2021
Q2 		$50K Buy
+1,963
New +$48.9K ﹤0.01% 5185

Other funds holding NVOS

AA
ACT Advisors Asheville, North Carolina $301M AUM 23.36% 1-Year Est. Return

BlackRock's NVOS Position: Q4 2024 in Review

BlackRock sold out of Novo Integrated Sciences, Inc. Common Stock (NVOS) in Q4 2024, closing a stake of 290,451 shares — an estimated $81.6K sold.

BlackRock first reported a position in NVOS in Q2 2021 and held it in 13 quarters. The position peaked at $871K in Q3 2023. 1 fund tracked by Wall St. Rank holds NVOS as of Q4 2024.

  • BlackRock reported no remaining Novo Integrated Sciences, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • BlackRock sold 290,451 Novo Integrated Sciences, Inc. Common Stock shares in Q4 2024, an estimated $81.6K.
  • BlackRock first reported a position in Novo Integrated Sciences, Inc. Common Stock in Q2 2021 and held it in 13 quarters.
  • BlackRock's Novo Integrated Sciences, Inc. Common Stock position peaked at $871K in Q3 2023.
  • 1 fund tracked by Wall St. Rank held Novo Integrated Sciences, Inc. Common Stock as of Q4 2024.

Based on BlackRock's 13F filing for Q4 2024, filed 7 Feb 2025.